
  
    
      
        Background_NNP
        Several_JJ active_JJ research_NN programs_NNS are_VBP investigating_VBG the_DT
        risk_NN associated_VBN with_IN serum_NN estrogens_NNS ,_, gonadotropins_NNS and_CC
        urinary_JJ sex_NN hormone_NN metabolites_NNS for_IN a_DT variety_NN of_IN diseases_NNS
        including_VBG breast_NN cancer_NN [_NN 1_CD ]_NN ,_, endometrial_NN cancer_NN [_NN 2_CD ]_NN ,_,
        and_CC osteoporosis_NNS [_NN 3_CD ]_NN ._. The_DT results_NNS of_IN the_DT few_JJ published_VBN
        studies_NNS suggest_VBP that_IN the_DT natural_JJ temporal_JJ variability_NN (_( true_JJ
        variation_NN over_IN time_NN ,_, not_RB variation_NN due_JJ to_TO storage_NN or_CC other_JJ
        factors_NNS )_) of_IN some_DT serum_NN estrogens_NNS ,_, gonadotropins_NNS and_CC urinary_JJ
        sex_NN hormone_NN metabolites_NNS is_VBZ sufficiently_RB great_JJ that_IN a_DT single_JJ
        measurement_NN occasion_NN may_MD be_VB inadequate_JJ to_TO ensure_VB a_DT reliable_JJ
        estimate_NN [_NN 4_CD 5_CD 6_CD ]_NN ._. Published_VBN intraclass_NNS correlation_NN
        coefficients_NNS (_( ICC_NNP )_) vary_VBP between_IN 0_CD ._. 06_CD and_CC 0_CD ._. 62_CD for_IN estradiol_NN
        (_( E_NNP 
        2_LS )_) and_CC between_IN 0_CD ._. 52_CD and_CC 0_CD ._. 69_CD for_IN
        estrone_NN (_( E_NNP 
        1_LS )_) [_NN 4_CD ]_NN ._. Only_RB the_DT percent_NN of_IN free_JJ E_NNP 
        2_CD and_CC of_IN SHBG-bound_NNP E_NNP 
        2_CD have_VBP been_VBN found_VBN to_TO be_VB sufficiently_RB
        reliable_JJ to_TO account_VB for_IN as_RB much_JJ as_IN 50_CD %_NN of_IN the_DT variance_NN in_IN
        the_DT true_JJ mean_NN (_( 
        ICC_NNP >_NN 0_CD ._. 7_CD )_) ._.
        The_DT term_NN reliability_NN can_MD refer_VB either_CC to_TO the_DT consistency_NN
        of_IN a_DT measuring_VBG procedure_NN or_CC to_TO the_DT temporal_JJ stability_NN of_IN
        the_DT target_NN of_IN measurement_NN [_NN 7_CD ]_NN ._. The_DT definition_NN of_IN
        temporal_JJ reliability_NN used_VBN in_IN this_DT study_NN includes_VBZ both_DT those_DT
        dimensions_NNS ,_, but_CC emphasizes_VBZ the_DT latter_NN ._. While_IN researchers_NNS
        can_MD control_VB error_NN due_JJ to_TO insufficient_JJ repeated_VBN measures_NNS by_IN
        increasing_VBG the_DT number_NN of_IN measurement_NN occasions_NNS ,_, obtaining_VBG
        measurements_NNS is_VBZ expensive_JJ ._. It_PRP is_VBZ therefore_RB useful_JJ to_TO have_VB
        evidence-based_JJ guidelines_NNS for_IN estimating_VBG the_DT minimum_JJ number_NN
        of_IN occasions_NNS required_VBN to_TO obtain_VB a_DT given_VBN degree_NN of_IN
        reliability_NN for_IN a_DT particular_JJ analyte_NN ._.
        All_DT types_NNS of_IN measurement_NN error_NN distort_VB ,_, confound_NN ,_, or_CC
        attenuate_NN the_DT tests_NNS of_IN association_NN that_WDT constitute_VBP one_CD of_IN
        the_DT primary_JJ products_NNS of_IN research_NN [_NN 8_CD 9_CD ]_NN ._. Figure_NN 1_CD ,_, though_IN
        not_RB exhaustive_JJ ,_, shows_VBZ the_DT sources_NNS of_IN variance_NN in_IN a_DT
        measurement_NN and_CC the_DT interrelationships_NNS between_IN error_NN and_CC
        tests_NNS of_IN model_NN fit_NN or_CC significance_NN ._.
        The_DT relation_NN of_IN a_DT measurement_NN to_TO the_DT object_NN being_VBG
        measured_VBN can_MD be_VB represented_VBN as_IN :_: σ_NN 
        
          O_NNP 
         =_SYM σ_NN 
        
          T_NN 
         +_NN σ_NN 
        
          E_NNP 
         ,_, where_WRB σ_NN 
        
          O_NNP 
         =_SYM variance_NN in_IN the_DT observed_VBN measurement_NN of_IN the_DT target_NN ,_,
        σ_NN 
        
          T_NN 
         =_SYM variance_NN in_IN the_DT true_JJ value_NN of_IN the_DT target_NN ,_, and_CC σ_NN 
        
          E_NNP 
         =_SYM random_JJ variance_NN ,_, or_CC error_NN ._. If_IN the_DT true_JJ value_NN of_IN the_DT
        target_NN is_VBZ invariant_NN across_IN measurements_NNS ,_, i_NNP ._. e_SYM ._. ,_, if_IN σ_NN 
        
          O_NNP 
         =_SYM σ_NN 
        
          E_NNP 
         ,_, the_DT observed_VBN variance_NN will_MD be_VB purely_RB a_DT function_NN of_IN
        the_DT unreliability_NN of_IN the_DT measuring_VBG instrument_NN ._. Conversely_RB ,_,
        if_IN perfectly_RB error-free_JJ measurement_NN of_IN the_DT target_NN could_MD be_VB
        assumed_VBN ,_, i_NNP ._. e_SYM ._. ,_, if_IN σ_NN 
        
          E_NNP 
         =_SYM 0_CD ,_, then_RB σ_NN 
        
          O_NNP 
         =_SYM σ_NN 
        
          T_NN 
         and_CC the_DT observed_VBN variance_NN would_MD be_VB purely_RB a_DT function_NN
        of_IN the_DT temporal_JJ stability_NN of_IN the_DT target_NN ._. If_IN σ_NN 
        
          E_NN 
         ≠_NN 0_CD and_CC σ_NN 
        
          T_NN 
         ≠_NN 0_CD ,_, the_DT observed_VBN variance_NN will_MD be_VB a_DT function_NN of_IN both_DT
        the_DT temporal_JJ stability_NN of_IN the_DT target_NN and_CC of_IN the_DT
        unreliability_NN of_IN the_DT measuring_VBG instrument_NN ._.
        Measurement_NNP error_NN can_MD result_VB from_IN a_DT variety_NN of_IN factors_NNS ,_,
        including_VBG true_JJ variance_NN not_RB captured_VBN by_IN a_DT particular_JJ
        measurement_NN strategy_NN ,_, which_WDT may_MD complicate_VB the_DT
        interpretation_NN of_IN temporal_JJ reliability_NN estimates_NNS ._. These_DT
        other_JJ factors_NNS include_VBP variance_NN due_JJ to_TO :_: fluctuations_NNS across_IN
        cycle_NN phases_NNS within_IN each_DT woman_NN 's_POS menstrual_JJ cycle_NN [_NN 10_CD ]_NN ;_:
        duration_NN of_IN sample_NN storage_NN prior_RB to_TO analysis_NN [_NN 11_CD ]_NN ;_:
        limitations_NNS of_IN the_DT assay_NN ;_: multiple_JJ analysis_NN batches_NNS [_NN 10_CD ]_NN
        ;_: multiple_JJ types_NNS of_IN assays_NNS [_NN 12_CD ]_NN ;_: and_CC multiple_JJ
        laboratories_NNS [_NN 10_CD ]_NN ._. Ideally_RB ,_, estimates_NNS of_IN as_IN many_JJ sources_NNS
        of_IN error_NN as_IN possible_JJ should_MD be_VB included_VBN when_WRB considering_VBG
        the_DT impact_NN of_IN temporal_JJ reliability_NN on_IN measurement_NN strategy_NN ._.
        The_DT objective_NN of_IN this_DT study_NN was_VBD to_TO determine_VB the_DT following_VBG
        for_IN various_JJ serum_NN estrogens_NNS ,_, gonadotropins_NNS ,_, and_CC urinary_JJ sex_NN
        hormone_NN metabolites_NNS :_: the_DT minimum_JJ number_NN of_IN repeated_VBN
        measurements_NNS required_VBN for_IN reliable_JJ estimates_NNS ;_: the_DT 
        ICC_NNP s_VBZ ;_: and_CC the_DT amount_NN of_IN true_JJ
        variance_NN accounted_VBD for_IN by_IN single_JJ measurements_NNS ._.
      
      
        Methods_NNP
        
          Experimental_NNP design_NN
          The_DT data_NNS for_IN this_DT study_NN come_VB from_IN a_DT randomized_JJ
          double-blind_JJ study_NN investigating_VBG the_DT effects_NNS of_IN a_DT 100_CD
          mg_NN /_NN day_NN soy_NN isoflavone_NN regimen_NN on_IN estrogen_NN levels_NNS in_IN 34_CD
          premenopausal_NN women_NNS ._. A_DT detailed_VBN description_NN of_IN the_DT study_NN
          design_NN and_CC the_DT results_NNS of_IN the_DT intervention_NN were_VBD reported_VBN
          in_IN Maskarinec_NNP et_CC al_NN ._. ,_, 2002_CD )_) ._. )_) [_NN 13_CD ]_NN ._. The_DT Committee_NNP on_IN
          Human_NNP Studies_NNPS at_IN the_DT University_NNP of_IN Hawaii_NNP approved_VBD the_DT
          study_NN protocol_NN ._. Written_VBN informed_VBN consent_NN was_VBD obtained_VBN
          from_IN each_DT subject_NN ,_, prior_RB to_TO participation_NN ._. The_DT study_NN
          group_NN consisted_VBD of_IN 17_CD premenopausal_NN women_NNS per_IN group_NN ._. Four_CD
          women_NNS left_VBD the_DT study_NN before_IN the_DT end_NN of_IN the_DT year_NN and_CC
          another_DT was_VBD able_JJ to_TO give_VB only_RB four_CD blood_NN draws_VBZ for_IN health_NN
          reasons_NNS ._. Eligibility_NNP criteria_NNS included_VBD :_: an_DT age_NN range_NN of_IN
          35_CD -_: 46_CD years_NNS ;_: an_DT average_JJ intake_NN of_IN less_JJR than_IN 7_CD servings_NNS of_IN
          soy_NN foods_NNS per_IN week_NN ;_: no_DT prior_JJ cancer_NN diagnosis_NN (_( except_IN
          basal_NN cell_NN skin_NN carcinoma_NN )_) ;_: no_DT use_NN of_IN oral_JJ contraceptives_NNS
          or_CC hormone_NN preparations_NNS within_IN the_DT past_JJ three_CD months_NNS ;_: no_DT
          intention_NN of_IN becoming_VBG pregnant_JJ within_IN the_DT next_JJ year_NN ;_: an_DT
          intact_JJ uterus_NN and_CC ovaries_NNS ;_: self-defined_JJ regular_JJ menstrual_JJ
          periods_NNS ;_: no_DT serious_JJ medical_JJ condition_NN ._. Subjects_NNP had_VBD a_DT
          mean_JJ age_NN of_IN 42_CD ._. 3_LS years_NNS (_( SD_NNP =_SYM 2_CD ._. 6_CD )_) ,_, and_CC a_DT mean_JJ weight_NN of_IN
          65_CD ._. 6_CD kg_NN (_( SD_NNP =_SYM 12_CD ._. 8_CD )_) ._. Subjects_NNP were_VBD ethnically_RB diverse_JJ :_: 18_CD
          were_VBD Caucasian_NNP ;_: 6_CD were_VBD Chinese_JJ ;_: 5_CD were_VBD Japanese_JJ ;_: 5_CD were_VBD
          Hawaiian_JJ ._.
        
        
          Sample_NNP collection_NN
          Subjects_NNP were_VBD asked_VBN to_TO donate_VB 5_CD urine_NN and_CC blood_NN
          samples_NNS ,_, one_CD at_IN baseline_NN and_CC one_CD after_IN 1_CD ,_, 3_CD ,_, 6_CD ,_, and_CC 12_CD
          months_NNS of_IN participation_NN ._. All_DT samples_NNS were_VBD collected_VBN
          approximately_RB 5_CD days_NNS after_IN the_DT ovulation_NN (_( approximately_RB
          day_NN 19_CD in_IN a_DT 28_CD day_NN cycle_NN )_) ._. Subjects_NNP used_VBD ovulation_NN kits_NNS
          (_( Ovuquick_NNP test_NN kits_NNS from_IN Quidel_NNP ,_, La_NNP Jolla_NNP ,_, CA_NNP )_) to_TO
          determine_VB the_DT time_NN of_IN ovulation_NN ._. This_DT kit_NN detects_NNS the_DT
          mid-cycle_JJ rise_NN of_IN LH_NNP using_VBG morning_NN urine_NN with_IN a_DT
          sensitivity_NN of_IN 35_CD mIU_NN /_NN mL_NN of_IN LH_NNP and_CC its_PRP$ predictive_JJ
          validity_NN with_IN respect_NN to_TO ovulation_NN has_VBZ been_VBN estimated_VBN as_IN
          93_CD %_NN [_NN 14_CD ]_NN ._. Although_IN the_DT use_NN of_IN a_DT minimum_JJ progesterone_NN
          value_NN to_TO exclude_VB data_NNS from_IN anovulatory_NN cycles_NNS from_IN the_DT
          analyses_NNS helped_VBD ensure_VB acquisition_NN of_IN the_DT mid-luteal_JJ
          phase_NN samples_NNS ,_, only_RB 52_CD %_NN of_IN samples_NNS were_VBD obtained_VBN on_IN
          exactly_RB the_DT 5_CD thday_NN from_IN ovulation_NN ._. Ninety-one_NNP percent_NN
          were_VBD obtained_VBN between_IN the_DT 4_CD thand_NN the_DT 6_CD thday_NN from_IN
          ovulation_NN ._. Blood_NNP samples_NNS were_VBD drawn_VBN at_IN a_DT commercial_JJ
          laboratory_NN ,_, in_IN the_DT morning_NN between_IN 7_CD and_CC 9_CD o'clock_RB to_TO
          control_VB for_IN circadian_NN rhythm_NN in_IN hormone_NN levels_NNS ._. Serum_NNP and_CC
          urine_NN samples_NNS were_VBD stored_VBN at_IN -_: 80_CD °_NN C_NNP after_IN separation_NN and_CC
          aliquoting_VBG ._.
        
        
          Serum_NNP analysis_NN
          Hormone_NNP assays_NNS were_VBD conducted_VBN at_IN the_DT Department_NNP of_IN
          Obstetrics_NNP and_CC Gynecology_NNP ,_, University_NNP of_IN Southern_NNP
          California_NNP (_( Los_NNP Angeles_NNP ,_, CA_NNP )_) in_IN the_DT Reproductive_NNP
          Endocrine_NNP Research_NNP Laboratory_NNP ._. The_DT analyses_NNS for_IN E_NNP 
          2_CD ,_, free_JJ E_NNP 
          2_CD ,_, E_NNP 
          1_CD ,_, E_NNP 
          1_CD S_NNP ,_, progesterone_NN ,_, SHBG_NNP ,_, follicle_NN
          stimulating_VBG hormone_NN (_( FSH_NNP )_) ,_, and_CC LH_NNP were_VBD conducted_VBN in_IN 2_CD
          batches_NNS ._. Samples_NNP of_IN these_DT analytes_NNS collected_VBN at_IN baseline_NN ,_,
          month_NN 1_CD and_CC month_NN 3_CD were_VBD analyzed_VBN in_IN batch_NN 1_CD ,_, and_CC 6_CD -_: month_NN
          and_CC 12_CD -_: month_NN samples_NNS were_VBD analyzed_VBN in_IN batch_NN 2_CD one_CD year_NN
          later_RB ._. E_NNP 
          2_CD ,_, E_NNP 
          1_CD ,_, progesterone_NN ,_, FSH_NNP ,_, LH_NNP ,_, and_CC SHBG_NNP
          were_VBD quantified_VBN in_IN serum_NN by_IN specific_JJ and_CC sensitive_JJ
          radioimmunoassays_NNS (_( RIAs_NNP )_) ._. Prior_RB to_TO RIA_NNP ,_, E_NNP 
          1_CD and_CC E_NNP 
          2_CD were_VBD first_RB extracted_VBN with_IN ethyl_NN
          acetate_NN :_: hexane_NN (_( 2_CD :_: 3_LS )_) and_CC then_RB purified_JJ by_IN Celite_NNP column_NN
          partition_NN chromatography_NN ,_, using_VBG ethylene_NN glycol_NN as_IN
          stationary_JJ phase_NN [_NN 15_CD ]_NN ._. E_NNP 
          1_CD and_CC E_NNP 
          2_CD were_VBD eluted_JJ off_IN the_DT column_NN with_IN 15_CD %_NN
          and_CC 40_CD %_NN toluene_NN in_IN isooctane_NN ,_, respectively_RB ._. 3_LS H-E_NNP 
          1_CD and_CC 3_CD H-E_NNP 
          2_CD were_VBD used_VBN as_IN internal_JJ standards_NNS to_TO
          follow_VB procedural_JJ losses_NNS ._. FSH_NNP and_CC LH_NNP levels_NNS were_VBD
          determined_VBN using_VBG an_DT immunoradiometric_JJ assay_NN (_( IRMA_NNP )_) ._. E_NNP 
          1_CD S_NNP ,_, progesterone_NN and_CC SHBG_NNP were_VBD
          measured_VBN by_IN direct_JJ RIAs_NNP using_VBG kits_NNS obtained_VBN from_IN
          Diagnostic_NNP Systems_NNPS Laboratories_NNPS ,_, Webster_NNP ,_, Texas_NNP ._. Free_NNP E_NNP 
          2_CD (_( non-_NN SHBG_NNP or_CC albumin-bound-_JJ E_NNP 
          2_LS )_) was_VBD determined_VBN by_IN calculation_NN
          using_VBG a_DT computerized_JJ algorithm_NN described_VBD previously_RB )_) ._. )_) [_NN
          16_CD ]_NN ._. The_DT majority_NN of_IN intra-assay_JJ CVs_NNP for_IN all_DT analytes_NNS
          were_VBD below_IN 10_CD %_NN (_( Table_NNP 1_LS )_) indicating_VBG good_JJ quality_NN control_NN
          in_IN the_DT laboratory_NN ._. They_PRP ranged_VBD from_IN <_NN 0_CD ._. 5_LS %_NN for_IN SHBG_NNP to_TO
          13_CD ._. 0_CD %_NN in_IN the_DT low_JJ concentration_NN range_NN of_IN batch_NN 1_CD for_IN E_NNP 
          1_CD ._.
        
        
          Urine_NNP analysis_NN
          Urine_NNP samples_NNS were_VBD analyzed_VBN for_IN estrone-_NN 3_CD -_: glucuronide_NN
          (_( E_NNP 
          1_CD -_: G_NNP )_) ,_, pregnanediol-_NN 3_CD -_: glucuronide_NN
          (_( PDG_NNP )_) ,_, 16_CD α-hydroxyestrone_JJ (_( 16_CD α-_NN OHE_NNP 
          1_LS )_) and_CC 2_CD -_: hydroxyestrone_NN (_( 2_CD -_: OHE_NNP 
          1_LS )_) ._. E_NNP 
          1_CD -_: G_NNP and_CC PDG_NNP were_VBD measured_VBN directly_RB in_IN
          urine_NN by_IN enzyme_NN immunoassay_NN [_NN 17_CD ]_NN ._. Commercially_NNP
          available_JJ enzyme-linked_JJ immunosorbent_NN assay_NN kits_NNS
          (_( Estramet_NNP :_: Immuna_NNP Care_NNP Corporation_NNP ,_, Bethlehem_NNP ,_, PA_NNP )_) were_VBD
          used_VBN to_TO determine_VB levels_NNS of_IN 16_CD α-_NN OHE_NNP 
          1_CD and_CC 2_CD -_: OHE_NNP 
          1_CD in_IN urine_NN [_NN 18_CD ]_NN ._. All_DT results_NNS are_VBP
          relative_JJ to_TO creatinine_NN excretion_NN ._.
        
        
          Statistical_NNP analysis_NN
          The_DT SAS_NNP statistical_JJ software_NN package_NN version_NN 8_CD ._. 2_CD (_( SAS_NNP
          Institute_NNP Inc_NNP ._. ,_, Cary_NNP ,_, NC_NNP ,_, 1999_CD -_: 2001_CD )_) was_VBD used_VBN to_TO perform_VB
          the_DT statistical_JJ analyses_NNS ._. All_DT statistics_NNS were_VBD computed_JJ
          using_VBG logged_VBN values_NNS when_WRB raw_JJ values_NNS were_VBD not_RB normally_RB
          distributed_VBN ._. To_TO ensure_VB that_IN all_DT measurements_NNS in_IN the_DT
          analysis_NN were_VBD from_IN the_DT same_JJ time_NN in_IN the_DT menstrual_JJ cycle_NN ,_,
          observations_NNS were_VBD only_RB included_VBN if_IN the_DT concurrent_JJ
          progesterone_NN values_NNS were_VBD at_IN least_JJS 5_CD ng_NN /_NN mL_NN ,_, a_DT minimum_JJ
          value_NN after_IN an_DT ovulation_NN has_VBZ occurred_VBN ._. Because_IN analyses_NNS
          for_IN 8_CD of_IN 12_CD analytes_NNS were_VBD conducted_VBN in_IN two_CD batches_NNS ,_, we_PRP
          included_VBD consideration_NN of_IN error_NN due_JJ to_TO between_IN batch_NN
          variance_NN in_IN our_PRP$ analysis_NN of_IN the_DT temporal_JJ stability_NN of_IN
          these_DT analytes_NNS ._. Therefore_RB ,_, estimates_NNS of_IN temporal_JJ
          stability_NN for_IN the_DT 8_CD analytes_NNS were_VBD calculated_VBN for_IN the_DT
          total_JJ number_NN of_IN samples_NNS and_CC for_IN the_DT first_JJ and_CC second_JJ
          batches_NNS separately_RB ._.
          Two_CD types_NNS of_IN estimates_NNS of_IN the_DT number_NN of_IN measurement_NN
          occasions_NNS (_( 
          O_NNP )_) necessary_JJ to_TO obtain_VB an_DT
          adequately_RB reliable_JJ estimate_NN were_VBD computed_JJ ._. The_DT first_JJ ,_,
          the_DT relative_JJ type_NN (_( 
          O_NNP 
          
            R_NN 
           )_) includes_VBZ the_DT between-subject_JJ variance_NN ._. 
          O_NNP 
          
            R_NN 
           was_VBD computed_JJ using_VBG the_DT formula_NN proposed_VBN by_IN Nelson_NNP et_CC
          al_NN ._. [_NN 19_CD ]_NN :_: where_WRB 
          r_LS is_VBZ the_DT correlation_NN between_IN the_DT
          observed_VBN and_CC the_DT true_JJ mean_NN analyte_NN values_NNS for_IN an_DT
          individual_NN over_IN a_DT year_NN ,_, 
          s_VBZ 
          
            W_NNP 
           2_CD is_VBZ the_DT within-subject_JJ variance_NN ,_, and_CC 
          s_VBZ 
          
            B_NNP 
           2_CD is_VBZ the_DT between-subject_JJ variance_NN ._. Setting_VBG 
          r_LS to_TO 0_CD ._. 9_CD results_NNS in_IN a_DT calculation_NN
          of_IN the_DT number_NN of_IN measurement_NN occasions_NNS required_VBN to_TO obtain_VB
          an_DT estimate_NN that_WDT would_MD account_VB for_IN 0_CD ._. 9_CD 2_CD or_CC 81_CD %_NN of_IN the_DT
          true_JJ variance_NN in_IN the_DT target_NN ._. Ninety-five_NNP percent_NN
          confidence_NN intervals_NNS (_( 95_CD %_NN CI_NNP )_) for_IN 
          O_NNP 
          
            R_NN 
           were_VBD computed_JJ using_VBG a_DT published_VBN method_NN )_) ._. )_) [_NN 20_CD ]_NN
          ._.
          The_DT second_JJ estimate_NN of_IN the_DT number_NN of_IN measurement_NN
          occasions_NNS necessary_JJ to_TO obtain_VB an_DT adequately_RB reliable_JJ
          estimate_NN ,_, the_DT absolute_JJ type_NN (_( 
          O_NNP 
          
            A_DT 
           )_) ,_, includes_VBZ only_RB within-subject_JJ variance_NN ._. 
          O_NNP 
          
            A_DT 
           was_VBD calculated_VBN as_IN ,_, where_WRB σ_NN 
          w_NN is_VBZ the_DT within-subject_JJ variance_NN [_NN 21_CD
          ]_NN ._. By_IN adjusting_VBG the_DT denominator_NN ,_, this_DT method_NN allows_VBZ for_IN
          the_DT desired_VBN approximation_NN to_TO the_DT true_JJ mean_NN to_TO be_VB
          specified_VBN as_IN a_DT percentage_NN ._. Setting_VBG the_DT denominator_NN to_TO 0_CD ._. 2_CD
          results_NNS in_IN a_DT calculation_NN of_IN the_DT number_NN of_IN occasions_NNS
          required_VBN to_TO obtain_VB an_DT estimate_NN that_WDT is_VBZ within_IN 20_CD %_NN of_IN the_DT
          true_JJ mean_NN ._. A_DT SAS_NNP macro_NN using_VBG Proc_NNP Varcomp_NNP and_CC Proc_NNP Means_NNP
          to_TO produce_VB estimates_NNS of_IN 
          O_NNP 
          
            R_NN 
           ,_, 
          O_NNP 
          
            A_DT 
           ,_, and_CC related_VBD statistics_NNS is_VBZ available_JJ from_IN the_DT
          authors_NNS ._.
          
          ICC_NNP s_VBZ measure_NN the_DT proportion_NN of_IN
          variance_NN attributable_JJ to_TO targets_NNS of_IN measurement_NN as_IN a_DT
          ratio_NN of_IN within-subject_JJ variance_NN to_TO total_VB variance_NN [_NN 22_CD ]_NN
          and_CC are_VBP suitable_JJ to_TO compare_VB variables_NNS of_IN the_DT same_JJ
          measurement_NN class_NN [_NN 23_CD ]_NN ._. We_PRP computed_JJ two_CD types_NNS of_IN 
          ICC_NNP s_VBZ using_VBG the_DT notation_NN developed_VBN
          by_IN Shrout_NNP and_CC Fleiss_NNP [_NN 22_CD ]_NN :_: 
          ICC_NNP (_( 2_CD ,_, 1_LS )_) was_VBD computed_JJ for_IN each_DT
          analyte_NN using_VBG all_DT 5_CD measurement_NN occasions_NNS to_TO estimate_VB the_DT
          temporal_JJ reliability_NN of_IN the_DT analyte_NN ;_: 
          ICC_NNP (_( 2_CD ,_, k_NN )_) was_VBD computed_JJ between_IN
          batches_NNS to_TO estimate_VB the_DT contribution_NN of_IN between-batch_JJ
          variance_NN to_TO the_DT temporal_JJ reliability_NN estimate_NN ._. 
          ICC_NNP (_( 2_CD ,_, 1_LS )_) was_VBD computed_JJ as_IN 
          ICC_NNP (_( 2_CD ,_, 1_LS )_) =_SYM ,_, where_WRB 
          BMS_NNP is_VBZ the_DT between-subjects_JJ mean_NN
          square_JJ ,_, 
          EMS_NNP is_VBZ the_DT error_NN mean_NN square_JJ ,_, 
          k_NN is_VBZ the_DT number_NN of_IN observations_NNS ,_, 
          OMS_NNP is_VBZ the_DT observations_NNS mean_VBP
          square_JJ ,_, and_CC 
          n_NN is_VBZ the_DT number_NN of_IN subjects_NNS [_NN 22_CD ]_NN
          ._. 
          ICC_NNP (_( 2_CD ,_, k_NN )_) was_VBD computed_JJ as_IN 
          ICC_NNP (_( 2_CD ,_, k_NN )_) =_SYM ._. We_PRP applied_VBD the_DT
          formulas_NNS by_IN Shrout_NNP and_CC Fleiss_NNP [_NN 22_CD ]_NN to_TO obtain_VB 95_CD %_NN
          CIs_NNP ._.
          To_TO estimate_VB the_DT percentage_NN of_IN true_JJ variance_NN accounted_VBD
          for_IN by_IN a_DT single_JJ measurement_NN ,_, we_PRP assumed_VBD that_IN the_DT best_JJS
          available_JJ estimate_NN of_IN the_DT true_JJ variance_NN was_VBD the_DT total_JJ
          variance_NN for_IN all_DT occasions_NNS ._.
          After_IN calculating_VBG the_DT Pearson_NNP correlation_NN of_IN each_DT
          occasion_NN with_IN all_DT other_JJ occasions_NNS ,_, we_PRP considered_VBD the_DT
          squared_VBN average_NN of_IN these_DT correlations_NNS as_IN the_DT estimate_NN of_IN
          the_DT most_RBS likely_JJ percent_NN of_IN true_JJ variance_NN for_IN which_WDT a_DT
          single_JJ occasion_NN could_MD account_VB ._. We_PRP used_VBD the_DT formula_NN ,_,
          where_WRB %_NN σ_NN 
          
            T_NN 
           is_VBZ the_DT percent_NN of_IN true_JJ variance_NN ,_, 
          r_LS 
          
            T_NN 
           is_VBZ the_DT Pearson_NNP correlation_NN of_IN each_DT occasion_NN with_IN the_DT
          total_NN of_IN all_DT other_JJ occasions_NNS ,_, and_CC 
          o_NN is_VBZ the_DT number_NN of_IN occasions_NNS ._.
        
      
      
        Results_NNS
        Overall_RB means_VBZ ,_, number_NN of_IN samples_NNS ,_, and_CC means_VBZ by_IN
        measurement_NN occasion_NN for_IN all_DT analytes_NNS (_( Table_NNP 2_LS )_) indicate_VBP
        the_DT overall_JJ stability_NN for_IN the_DT analytes_NNS over_IN one_CD year_NN ._.
        Although_IN estrogen_NN and_CC progesterone_NN levels_NNS were_VBD on_IN the_DT
        average_JJ 7_CD %_NN higher_JJR and_CC gonadotropins_NNS and_CC urinary_JJ sex_NN hormone_NN
        metabolites_NNS 10_CD %_NN lower_JJR in_IN the_DT intervention_NN than_IN in_IN the_DT
        control_NN group_NN (_( data_NNS not_RB shown_VBN )_) ,_, none_NN of_IN the_DT differences_NNS was_VBD
        even_RB close_RB to_TO statistical_JJ significance_NN (_( 
        p_NN values_NNS ranged_VBD from_IN 
        p_NN =_SYM 0_CD ._. 16_CD to_TO 
        p_NN =_SYM 0_CD ._. 90_CD for_IN Estrone-sulfate_NNP and_CC
        Estrone_NNP respectively_RB )_) ._. Because_IN of_IN this_DT homogeneity_NN ,_, results_NNS
        in_IN this_DT study_NN were_VBD collapsed_VBN across_IN experimental_JJ groups_NNS ._.
        The_DT decrease_NN in_IN E_NNP 
        2_CD and_CC E_NNP 
        1_CD are_VBP the_DT result_NN of_IN laboratory_NN drift_NN and_CC
        were_VBD independent_JJ of_IN intervention_NN status_NN )_) ._. )_) [_NN 13_CD ]_NN ._.
        The_DT measurement_NN occasions_NNS required_VBN to_TO obtain_VB a_DT reliable_JJ
        estimate_NN differed_VBD considerably_RB by_IN analyte_NN (_( Table_NNP 3_LS )_) ._. Using_VBG
        the_DT relative_JJ method_NN to_TO account_VB for_IN 81_CD %_NN of_IN the_DT true_JJ
        variance_NN ,_, the_DT number_NN of_IN occasions_NNS required_VBN ranged_VBD from_IN 
        O_NNP 
        
          R_NN 
         =_SYM 0_CD ._. 48_CD to_TO 
        O_NNP 
        
          R_NN 
         =_SYM 11_CD ._. 43_CD (_( for_IN SHBG_NNP and_CC E_NNP 
        1_CD respectively_RB )_) ._. To_TO account_VB for_IN 64_CD %_NN of_IN
        the_DT true_JJ variance_NN ,_, the_DT number_NN of_IN occasions_NNS ranged_VBD from_IN 
        O_NNP 
        
          R_NN 
         =_SYM 0_CD ._. 20_CD to_TO 
        O_NNP 
        
          R_NN 
         =_SYM 4_CD ._. 77_CD (_( for_IN SHBG_NNP and_CC E_NNP 
        1_CD respectively_RB )_) ._. Using_VBG the_DT absolute_JJ
        method_NN ,_, the_DT number_NN of_IN occasions_NNS required_VBN to_TO obtain_VB an_DT
        estimate_NN to_TO within_IN 20_CD %_NN of_IN the_DT true_JJ mean_NN ,_, ranged_VBD from_IN 
        O_NNP 
        
          A_DT 
         =_SYM 0_CD ._. 34_CD to_TO 
        O_NNP 
        
          A_DT 
         =_SYM 10_CD ._. 27_CD (_( for_IN E_NNP 
        2_CD and_CC PDG_NNP respectively_RB )_) ._. It_PRP appears_VBZ
        that_IN ,_, except_IN for_IN SHBG_NNP and_CC E_NNP 
        1_CD S_NNP ,_, using_VBG a_DT single_JJ measurement_NN for_IN any_DT
        of_IN the_DT analytes_NNS in_IN this_DT analysis_NN may_MD be_VB problematic_JJ for_IN the_DT
        typical_JJ purposes_NNS of_IN epidemiological_JJ research_NN because_IN the_DT
        results_NNS of_IN typical_JJ epidemiological_JJ research_NN center_NN on_IN
        analyses_NNS of_IN the_DT mean_JJ value_NN obtained_VBN from_IN one_CD group_NN 
        vs_NNS ._. the_DT mean_JJ value_NN obtained_VBN from_IN
        another_DT ,_, e_SYM ._. g_SYM ._. a_DT group_NN of_IN cases_NNS or_CC an_DT intervention_NN group_NN 
        vs_NNS ._. a_DT control_NN group_NN ._.
        Figures_NNS 2_CD to_TO 4_CD illustrate_VBP the_DT different_JJ relationship_NN of_IN
        between-_NN to_TO within-subject_JJ variance_NN and_CC the_DT corresponding_JJ
        difference_NN between_IN 
        O_NNP 
        
          R_NN 
         and_CC 
        O_NNP 
        
          A_DT 
         ._.
        In_IN the_DT case_NN of_IN SHBG_NNP (_( Figure_NN 2_LS )_) ,_, within-subject_JJ variance_NN
        is_VBZ small_JJ relative_NN to_TO between-subject_JJ variance_NN ._. There_EX is_VBZ
        little_JJ variation_NN within_IN subjects_NNS relative_JJ to_TO the_DT variation_NN
        between_IN subjects_NNS ,_, resulting_VBG in_IN small_JJ 
        O_NNP 
        
          R_NN 
         and_CC 
        O_NNP 
        
          A_DT 
         estimates_NNS (_( 0_CD ._. 48_CD and_CC 1_CD ._. 78_CD respectively_RB )_) ._. The_DT PDG_NNP values_NNS
        (_( Figure_NN 3_LS )_) illustrate_VBP the_DT case_NN in_IN which_WDT within_IN subject_JJ
        variation_NN is_VBZ high_JJ and_CC overlap_VB one_CD another_DT considerably_RB ,_,
        resulting_VBG in_IN relatively_RB large_JJ 
        O_NNP 
        
          R_NN 
         and_CC 
        O_NNP 
        
          A_DT 
         estimates_NNS (_( 5_CD ._. 17_CD and_CC 10_CD ._. 27_CD respectively_RB )_) ._. Finally_RB ,_,
        Figure_NN 4_CD depicts_VBZ the_DT case_NN in_IN which_WDT within-subject_JJ variance_NN
        is_VBZ small_JJ ,_, but_CC so_RB is_VBZ the_DT variance_NN between_IN subjects_NNS ._. In_IN this_DT
        case_NN ,_, the_DT small_JJ within-subject_JJ variance_NN results_NNS in_IN a_DT small_JJ 
        O_NNP 
        
          A_DT 
         estimate_NN (_( 0_CD ._. 34_CD )_) ,_, but_CC because_IN the_DT within-subject_JJ
        variance_NN is_VBZ not_RB small_JJ relative_NN to_TO the_DT between-subject_JJ
        variance_NN ,_, the_DT 
        O_NNP 
        
          R_NN 
         is_VBZ relatively_RB large_JJ (_( 8_CD ._. 26_CD )_) ._.
        Because_IN 
        ICC_NNP s_VBZ include_VBP both_DT within-_NN and_CC
        between-subject_JJ variance_NN ,_, 
        ICC_NNP s_VBZ closely_RB followed_VBN 
        O_NNP 
        
          R_NN 
         rather_RB than_IN 
        O_NNP 
        
          A_DT 
         estimates_NNS ._. 
        ICC_NNP (_( 2_CD ,_, 1_LS )_) ranged_VBD from_IN 
        ICC_NNP (_( 2_CD ,_, 1_LS )_) =_SYM 0_CD ._. 30_CD to_TO 
        ICC_NNP (_( 2_CD ,_, 1_LS )_) =_SYM 0_CD ._. 88_CD (_( for_IN LH_NNP and_CC SHBG_NNP
        respectively_RB ,_, Table_NNP 3_LS )_) ._. The_DT intraclass_NNS correlation_NN
        coefficient_NN 
        ICC_NNP s_VBZ for_IN absolute_JJ agreement_NN between_IN
        the_DT two_CD analysis_NN batches_NNS ranged_VBD from_IN 
        ICC_NNP (_( 2_CD ,_, 1_LS )_) =_SYM 0_CD ._. 47_CD to_TO 
        ICC_NNP (_( 2_CD ,_, 1_LS )_) =_SYM 0_CD ._. 96_CD (_( for_IN E_NNP 
        1_CD and_CC SHBG_NNP respectively_RB ,_, Table_NNP 4_LS )_) ._.
        Estimates_NNS of_IN 
        ICC_NNP s_VBZ were_VBD ,_, generally_RB ,_, consistent_JJ
        across_IN batches_NNS ,_, with_IN similar_JJ estimates_NNS based_VBN on_IN analysis_NN of_IN
        all_DT 5_CD occasions_NNS and_CC for_IN estimates_NNS based_VBN on_IN each_DT batch_NN ._. The_DT
        between_IN batch_NN 
        ICC_NNP for_IN E_NNP 
        1_CD ,_, however_RB ,_, was_VBD less_JJR than_IN 0_CD ._. 5_CD ,_,
        suggesting_VBG that_IN the_DT batch_NN 1_CD 
        ICC_NNP may_MD be_VB a_DT better_JJR indicator_NN than_IN
        the_DT 
        ICC_NNP based_VBN on_IN all_DT samples_NNS ._. The_DT percent_NN
        of_IN true_JJ variance_NN accounted_VBD for_IN by_IN a_DT single_JJ measurement_NN
        ranged_VBD from_IN 29_CD %_NN to_TO 92_CD %_NN for_IN LH_NNP and_CC SHBG_NNP respectively_RB ._.
      
      
        Discussion_NNP
        We_PRP have_VBP provided_VBN estimates_NNS to_TO the_DT minimum_JJ number_NN of_IN
        measurement_NN occasions_NNS required_VBN to_TO ensure_VB adequate_JJ
        reliability_NN for_IN two_CD types_NNS of_IN experimental_JJ aims_NNS ._. Analyses_NNS in_IN
        epidemiologic_JJ studies_NNS involve_VBP calculations_NNS in_IN which_WDT
        between-subject_JJ as_IN well_RB as_IN within-subject_JJ variance_NN is_VBZ
        important_JJ ._. Therefore_RB ,_, 
        O_NNP 
        
          R_NN 
         will_MD usually_RB be_VB the_DT appropriate_JJ index_NN of_IN the_DT minimum_JJ
        number_NN of_IN occasions_NNS needed_VBN to_TO obtain_VB a_DT reliable_JJ estimate_NN ._.
        Estimates_NNS of_IN 
        O_NNP 
        
          R_NN 
         based_VBN on_IN our_PRP$ sample_NN suggest_VBP that_IN only_RB SHBG_NNP and_CC E_NNP 
        1_CD S_NNP had_VBD sufficient_JJ temporal_JJ stability_NN to_TO
        be_VB adequately_RB reliable_JJ with_IN a_DT single_JJ measurement_NN when_WRB the_DT
        desired_VBN amount_NN of_IN variance_NN to_TO account_VB for_IN was_VBD set_VBN as_RB low_JJ as_IN
        64_CD %_NN ._. A_DT single_JJ measurement_NN of_IN any_DT of_IN the_DT other_JJ analytes_NNS
        would_MD be_VB unlikely_JJ to_TO account_VB for_IN even_RB 50_CD %_NN of_IN the_DT true_JJ
        variance_NN ._. For_IN cases_NNS in_IN which_WDT the_DT within-subject_JJ variance_NN is_VBZ
        the_DT only_JJ variance_NN of_IN interest_NN ,_, e_SYM ._. g_SYM ._. ,_, when_WRB the_DT measured_VBN
        value_NN of_IN an_DT analyte_NN will_MD be_VB compared_VBN with_IN a_DT fixed_VBN standard_JJ ,_,
        
        O_NNP 
        
          A_DT 
         will_MD be_VB the_DT appropriate_JJ index_NN ._. The_DT omission_NN of_IN
        between-subject_JJ variance_NN from_IN the_DT formula_NN for_IN calculating_VBG
        this_DT statistic_NN produces_VBZ very_RB different_JJ results_NNS from_IN 
        O_NNP 
        
          R_NN 
         ._. Several_JJ of_IN the_DT analytes_NNS that_WDT were_VBD adequately_RB
        reliable_JJ with_IN a_DT single_JJ measurement_NN or_CC very_RB few_JJ
        measurements_NNS ,_, when_WRB between-subject_JJ variance_NN was_VBD a_DT factor_NN ,_,
        required_VBN higher_JJR numbers_NNS of_IN measures_NNS when_WRB only_RB
        within-subject_JJ variance_NN was_VBD involved_VBN and_CC vice_NN versa_RB ._.
        This_DT study_NN confirms_VBZ previous_JJ findings_NNS that_IN SHBG_NNP may_MD be_VB
        reliably_RB measured_VBN in_IN premenopausal_NN women_NNS using_VBG a_DT single_JJ
        occasion_NN ._. It_PRP also_RB indicates_VBZ that_IN E_NNP 
        1_CD S_NNP may_MD be_VB reliably_RB measured_VBN using_VBG one_CD
        sample_NN only_RB ._. More_RBR importantly_RB ,_, our_PRP$ results_NNS suggest_VBP that_DT
        none_NN of_IN the_DT other_JJ analytes_NNS examined_VBD meet_VB minimal_JJ
        reliability_NN requirements_NNS that_WDT would_MD permit_VB confidence_NN in_IN
        single_JJ measures_NNS ._. These_DT results_NNS are_VBP in_IN agreement_NN with_IN the_DT
        wide_JJ range_NN if_IN 
        ICCs_NNP reported_VBD in_IN previous_JJ studies_NNS [_NN 4_CD
        5_CD 6_CD ]_NN ._. Our_PRP$ conclusions_NNS are_VBP limited_VBN to_TO the_DT collection_NN of_IN
        samples_NNS at_IN midluteal_NN phase_NN ,_, however_RB ,_, and_CC may_MD not_RB generalize_VB
        to_TO other_JJ phases_NNS of_IN the_DT menstrual_JJ cycle_NN ._.
        The_DT use_NN of_IN 
        ICC_NNP s_VBZ to_TO estimate_VB the_DT agreement_NN
        between_IN analysis_NN batches_NNS differs_VBZ from_IN their_PRP$ use_NN as_IN an_DT index_NN
        of_IN temporal_JJ reliability_NN ._. The_DT appropriate_JJ type_NN of_IN 
        ICC_NNP for_IN this_DT purpose_NN uses_VBZ a_DT mean_NN of_IN
        several_JJ values_NNS rather_RB than_IN single_JJ values_NNS and_CC is_VBZ typically_RB
        higher_JJR than_IN that_DT calculated_VBD using_VBG single_JJ values_NNS ._. Though_IN the_DT
        
        ICC_NNP s_VBZ between_IN batches_NNS were_VBD higher_JJR
        than_IN those_DT estimating_VBG temporal_JJ reliability_NN ,_, they_PRP were_VBD
        relatively_RB low_JJ ,_, demonstrating_VBG the_DT importance_NN of_IN measuring_VBG
        all_DT samples_NNS in_IN one_CD batch_NN when_WRB possible_JJ ._. As_IN was_VBD previously_RB
        noted_VBN [_NN 11_CD ]_NN ,_, error_NN due_JJ to_TO time_NN in_IN storage_NN will_MD affect_VB
        estimates_NNS of_IN temporal_JJ reliability_NN ._. Analyzing_NNP in_IN multiple_JJ
        batches_NNS is_VBZ one_CD means_NNS of_IN decreasing_VBG this_DT source_NN of_IN error_NN ,_,
        but_CC runs_VBZ the_DT risk_NN of_IN increasing_VBG error_NN due_JJ to_TO multiple_JJ
        batches_NNS ._. Until_IN better_JJR estimates_NNS of_IN the_DT impact_NN of_IN storage_NN
        time_NN on_IN each_DT of_IN these_DT analytes_NNS are_VBP available_JJ ,_, however_RB ,_, it_PRP
        will_MD be_VB difficult_JJ to_TO draw_VB conclusions_NNS about_IN whether_IN error_NN
        due_JJ to_TO multiple_JJ analysis_NN batches_NNS or_CC error_NN due_JJ to_TO storage_NN
        time_NN has_VBZ the_DT more_RBR detrimental_JJ effect_NN on_IN temporal_JJ
        reliability_NN ._.
        Several_JJ sources_NNS of_IN error_NN are_VBP effectively_RB beyond_IN
        researchers_NNS '_POS capacity_NN to_TO control_VB ._. For_IN example_NN ,_, the_DT validity_NN
        and_CC reliability_NN of_IN the_DT best_JJS assay_NN available_JJ for_IN measuring_VBG a_DT
        given_VBN analyte_NN cannot_NN be_VB increased_VBN through_IN improving_VBG study_NN
        design_NN ._. Other_JJ sources_NNS of_IN error_NN ,_, however_RB ,_, can_MD be_VB
        dramatically_RB reduced_VBN through_IN the_DT use_NN of_IN appropriate_JJ
        designs_NNS ._. These_DT strategies_NNS may_MD include_VB ,_, increasing_VBG the_DT
        sample_NN size_NN to_TO reduce_VB the_DT impact_NN of_IN random_JJ error_NN ,_, analyzing_VBG
        all_DT samples_NNS in_IN one_CD batch_NN ,_, and_CC using_VBG a_DT sufficient_JJ number_NN of_IN
        repeated_VBN measures_NNS to_TO obtain_VB an_DT adequately_RB reliable_JJ
        estimate_NN ._. It_PRP is_VBZ also_RB possible_JJ ,_, though_IN not_RB uncontroversial_NN ,_,
        to_TO control_VB error_NN statistically_RB by_IN correcting_VBG for_IN
        attenuation_NN using_VBG validation_NN data_NNS [_NN 24_CD ]_NN ._.
        Several_JJ improvements_NNS ,_, in_IN addition_NN to_TO a_DT larger_JJR sample_NN and_CC
        more_RBR repeated_JJ measures_NNS ,_, would_MD have_VB increased_VBN confidence_NN in_IN
        the_DT results_NNS of_IN our_PRP$ study_NN ._. First_LS ,_, if_IN the_DT effects_NNS of_IN storage_NN
        time_NN on_IN the_DT analytes_NNS were_VBD known_VBN ,_, we_PRP could_MD have_VB taken_VBN into_IN
        account_NN the_DT contributions_NNS of_IN this_DT source_NN of_IN variance_NN to_TO our_PRP$
        temporal_JJ reliability_NN estimates_NNS and_CC distinguished_VBD its_PRP$ impact_NN
        from_IN that_DT due_JJ to_TO assay_NN reliability_NN ._. Second_JJ ,_, obtaining_VBG blood_NN
        and_CC urine_NN samples_NNS on_IN day_NN 5_CD following_VBG ovulation_NN was_VBD most_RBS
        appropriate_JJ for_IN the_DT measurement_NN of_IN progesterone_NN and_CC
        near-optimal_JJ for_IN SHBG_NNP ,_, but_CC may_MD not_RB have_VB been_VBN the_DT best_JJS day_NN
        to_TO obtain_VB estimates_NNS of_IN the_DT other_JJ analytes_NNS [_NN 25_CD ]_NN ._. Third_NNP ,_,
        though_IN our_PRP$ data_NNS were_VBD drawn_VBN from_IN an_DT intervention_NN study_NN in_IN
        which_WDT no_DT results_NNS approached_VBD significance_NN ,_, a_DT more_RBR clearly_RB
        homogeneous_JJ sample_NN would_MD have_VB been_VBN preferable_JJ ._. Fourth_JJ ,_,
        variation_NN in_IN menstrual_JJ cycle_NN length_NN and_CC variance_NN due_JJ to_TO
        pulsatility_NN of_IN excretion_NN were_VBD additional_JJ sources_NNS of_IN
        error_NN ._.
        Finally_RB ,_, our_PRP$ estimates_NNS were_VBD based_VBN on_IN targets_NNS that_WDT
        changed_VBD across_IN measurements_NNS ,_, and_CC we_PRP could_MD not_RB assume_VB
        error-free_JJ measurements_NNS ._. Consequently_RB ,_, we_PRP were_VBD not_RB able_JJ to_TO
        precisely_RB distinguish_VB between_IN the_DT contributions_NNS of_IN assay_NN
        reliability_NN and_CC the_DT contributions_NNS of_IN each_DT analyte_NN 's_POS natural_JJ
        variability_NN to_TO our_PRP$ estimates_NNS of_IN temporal_JJ reliability_NN ._.
        However_RB ,_, despite_IN some_DT limitations_NNS ,_, this_DT study_NN provided_VBD
        significant_JJ new_JJ insights_NNS into_IN the_DT variability_NN of_IN sex_NN
        hormones_NNS ,_, gonadotropins_NNS ,_, and_CC urinary_JJ hormone_NN metabolites_NNS in_IN
        premenopausal_NN women_NNS during_IN a_DT one-year_JJ period_NN ._. Our_PRP$ estimates_NNS
        of_IN temporal_JJ reliability_NN represent_VBP the_DT combined_VBN computation_NN
        of_IN the_DT consistency_NN of_IN a_DT measure_NN across_IN repeated_VBN
        measurements_NNS and_CC the_DT temporal_JJ fluctuations_NNS in_IN the_DT target_NN of_IN
        measurement_NN ._.
      
      
        Conclusions_NNP
        Given_VBN the_DT relatively_RB large_JJ sample_NN size_NN for_IN this_DT analysis_NN
        and_CC the_DT strictly_RB controlled_VBN protocol_NN to_TO collect_VB samples_NNS on_IN
        the_DT same_JJ day_NN of_IN the_DT menstrual_JJ cycle_NN ,_, our_PRP$ results_NNS will_MD be_VB
        useful_JJ for_IN designing_VBG future_JJ research_NN projects_NNS exploring_VBG the_DT
        role_NN of_IN sex_NN hormones_NNS in_IN the_DT etiology_NN of_IN cancer_NN and_CC other_JJ
        diseases_NNS ._.
      
      
        Competing_VBG interests_NNS
        This_DT project_NN was_VBD supported_VBN by_IN the_DT Pharmavite_NNP Corporation_NNP
        in_IN San_NNP Fernando_NNP ,_, California_NNP and_CC a_DT Developmental_NNP Funds_NNPS award_NN
        from_IN the_DT Cancer_NNP Center_NNP Support_NN grant_NN to_TO the_DT Cancer_NNP Research_NNP
        Center_NNP of_IN Hawaii_NNP (_( P_NN 30_CD CA_NNP 071789_CD )_) ._.
      
      
        Authors_NNP '_'' contributions_NNS
        AW_NNP conceived_VBD of_IN the_DT study_NN and_CC performed_VBD the_DT statistical_JJ
        analyses_NNS ._. GM_NNP was_VBD the_DT primary_JJ investigator_NN on_IN the_DT original_JJ
        study_NN from_IN which_WDT the_DT data_NNS for_IN this_DT study_NN was_VBD drawn_VBN and_CC
        contributed_VBN to_TO the_DT design_NN of_IN this_DT study_NN ._. FS_NNP carried_VBD out_RP the_DT
        immunoassays_NNS and_CC contributed_VBD to_TO the_DT writing-up_JJ of_IN this_DT
        study_NN ._. AF_NNP participated_VBD in_IN the_DT study_NN design_NN and_CC consulted_VBN
        with_IN the_DT authors_NNS ._.
      
    
  
